ÂÜÀòÂÒÂ×

Dr. Nagarajan Paramasivam currently serves as the Workflow Development Lead at the National Center for Tumor Diseases (NCT) Heidelberg, where responsibilities include developing computerized system validation for personalized cancer genomic data analysis workflows and leading a team of researchers. Previously, Dr. Paramasivam was a Senior Bioinformatics Scientist at NCT, focusing on cancer genomics and maintaining workflows for precision oncology programs. Prior experience includes a postdoctoral research fellowship at DKFZ, working on NGS data analysis for rare genetic diseases and cancer predisposition, and a PhD project at the Max Planck Institutes concentrating on vaccine development against Gram-negative bacteria. Educational qualifications include a Doctor of Science from the Max Planck Institute, a Master’s in Bioinformatics from Bharathiar University, and a Bachelor’s in Zoology with a specialization in Biotechnology.